No. The IMMray PanCan-d test is only intended for individuals at risk for developing familial or hereditary pancreatic cancer. Because pancreatic cancer is a low incidence disease, if the general population were screened for it, there would be a huge number of false positive results even with a very accurate test. As a result, it is recommended that only those at high risk for developing the disease be tested.
The IMMray PanCan-d Test Requisition form is available to download here, as is a brochure that provides additional information on the test. Please download and/or print both materials for your physician and start a discussion about whether the IMMray PanCan-d test is right for you. Contact Customer Support at 833-593-9522 if you need assistance accessing these documents or if you would prefer to have printed documents mailed to you.
No. This test is intended for individuals over 18 years old and there is currently no information about its performance in children. A person’s risk of developing pancreatic cancer increases with age, and it is very rare for children to develop pancreatic ductal adenocarcinoma. If you have a strong family history of pancreatic cancer and are concerned about your child’s risk, you may want to consider genetic testing for your child to have a better understanding of their inherited risk. Consider speaking with your child’s pediatrician about your child’s risk and if genetic testing is appropriate.
Yes, the IMMray PanCan-d test requires a physician order.
The IMMray PanCan-d test offers you an opportunity to discuss your family history of pancreatic cancer (or other diseases) with their physician. This pamphlet provides tips on how to speak with a physician about the test. If you would prefer that Immunovia, Inc. contact your doctor directly about the IMMray PanCan-d test, please complete the form on this page.
Immunovia, Inc. is working to get insurance coverage of the test as soon as possible. In the meantime, the test is available for self-pay only. Patients may also be able to use flexible spending accounts (FSAs) or health savings accounts (HSAs) to pay for the IMMray PanCan-d test, and financial assistance programs are available.
The IMMray PanCan-d test is only available via patient pay as we seek insurance coverage. We have a number of income-based financial assistance programs as well as prompt pay discounts outlined here to make the test accessible. The list price of the IMMray PanCan-d test is $995, but if you pay within 14 days of receiving the invoice, the cost is $746, and as low as $200 (or less) if you qualify for income-based financial assistance.
Patients may also be able to use flexible spending accounts (FSAs) or health savings accounts (HSAs) to pay for the IMMray PanCan-d test.
Contact our Customer Support team for additional information, including payment plan options, at 833-593-9522 between 8 AM and 5 PM Eastern Time.
Yes, Immunovia, Inc. has a number of financial assistance programs. Learn more on this page or contact Customer Support at 833-593-9522 to get more information.
Yes, Immunovia, Inc. is able to accept specimens from outside the U.S. for processing with the IMMray PanCan-d test. If you live outside the U.S. and are interested in getting tested with IMMray PanCan-d, please call our Customer Support team at +1 508 803-9721 or email them at firstname.lastname@example.org. They will help guide you through the process.
Customer Support will contact you to explain the test process, schedule a phlebotomy appointment, and answer any questions you may have. After your sample is received and processed, the test result will be sent to your physician, who is responsible for sharing test results with you.
An experienced phlebotomist will draw your blood sample at a patient service center convenient to you. Our Customer Support team will help you find a local location and arrange the appointment at a time convenient for your schedule.
Immunovia, Inc. and its phlebotomy partners take the COVID-19 pandemic seriously. All contracted phlebotomists wear masks and gloves at all times, and their health is monitored carefully. All procedures will be reviewed and updated frequently to reduce the spread of COVID-19.
Once your blood sample is collected, it will be placed in a self-cooling shipping box (NanoCool®) and shipped overnight to Immunovia, Inc. in Marlborough, Massachusetts for processing.
All IMMray PanCan-d test results are provided to the ordering provider, who then shares the results with the patient.
Test results are provided to the ordering physician 5 to 7 business days after the sample is received at Immunovia, Inc.
You should contact your physician with any questions about your test result. If your physician has questions about the IMMray PanCan-d test result, he or she can contact Dr. Thomas King, Immunovia, Inc.’s Medical Director, by calling Customer Support at 833-593-9522.
You can contact Customer Support at 833-593-9522 for assistance with rescheduling your blood collection appointment.
In the unlikely event that your blood sample takes longer than 48 hours to arrive at Immunovia, Inc., another blood sample will need to be collected for the IMMray PanCan-d test. In that case, our Customer Support team will reach out to you to explain the issue and start the process for a new blood collection. You will not be charged for the second blood test, and you will only be charged once your test result report has been sent to the ordering provider.
If you receive a “High-Risk Signature Present” result with the IMMray PanCan-d test, your doctor will likely order imaging of your pancreas. If your test was ordered by a primary care practitioner, you may also be referred to a gastroenterologist for further testing and workup.
The IMMray PanCan-d test includes CA19-9 levels in the algorithm to improve the accuracy of the test. These levels are included in the test report to provide further clinical information to the ordering physician.
A Borderline test result means that your blood sample result could not be assigned a High-Risk Signature Present or Negative for High-Risk Signature result with greater than 90% confidence. A Borderline result is not a failure of the test; it means the sample quality was adequate. Retesting with a new sample may clarify the results. Typically, approximately 10% of samples analyzed yield a Borderline IMMray PanCan-d result.
A result of Test Not Performed means that Immunovia, Inc. was unable to process the specimen in our lab, usually because of the quality of the specimen. This can be caused by shipping delays, or conditions during travel where the specimen temperature increased above 8°C.
No. Patients are only charged for IMMray PanCan-d tests that are processed and provide a valid result of High-Risk Signature Present, Negative for High-Risk Signature or Borderline.
Any questions about your bill should be directed to Customer Support at 833-593-9522.
NanoCool is a registered trademark of Pelican BioThermal, LLC.